US doctors treat man for rare genetic disorder by editing DNA in world first

Credit
A US man with Hunter syndrome, a rare genetic disorder, has become the first human patient to trial a gene-editing
treatment inside his body.
Key points:
- Brian Madeux, 44, is undergoing gene therapy for rare metabolic disorder Hunter syndrome
- California-based Sangamo Therapeutics is able to target a specific gene inside the body
- While the technology carry risks, there is huge potential for better treatments in future
Scientists acknowledge that gene-editing procedures carry potential risks, but there is huge potential too for better
treatments for patients in future.
Brian Madeux, a 44-year-old man with the inherited metabolic disorder, has had 26 surgeries to treat his symptoms,
and said he has a lot of hope for this new treatment.
"Gene therapy, I've been waiting for that my whole life," Mr Madeux said.
Gene editing, where a gene is inserted into a patient's DNA, has been around since the 1980s.
But Mr Madeux's procedure promises to be far more precise than ever before.
More Here
Now, since we have the power to edit DNA ... which Member would benefit by a Personality Transplant?